| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 7 917-922, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
PN Cockerill, CS Osborne, AG Bert and RJ Grotto
Division of Human Immunology, Hanson Centre For Cancer Research, Institute for Medical and Veterinary Science, Adelaide, Australia.
GM-CSF gene activation in T cells is known to involve the transcription factors nuclear factor-kappa B, AP-1, NFAT, and Sp1. Here we demonstrate that the human GM-CSF promoter and enhancer also encompass binding sites for core-binding factor (CBF). Significantly, the CBF sites are in each case contained within the minimum essential core regions required for inducible activation of transcription. Furthermore, these core regions of the enhancer and promoter each encompass closely linked binding sites for CBF, AP-1, and NFATp. The GM-CSF promoter CBF site TGTGGTCA is located 51 bp upstream of the transcription start site and also overlaps a YY-1 binding site. A 2-bp mutation within the CBF site resulted in a 2-3-fold decrease in the activities of both a 69-bp proximal promoter fragment and a 627-bp full-length promoter fragment. Stepwise deletions into the proximal promoter also revealed that the CBF site, but not the YY-1 site, was required for efficient induction of transcriptional activation. The AML1 and CBF beta genes that encode CBF each have the ability to influence cell growth and differentiation and have been implicated as proto-oncogenes in acute myeloid leukemia. This study adds GM-CSF to a growing list of cytokines and receptors that are regulated by CBF and which control the growth, differentiation, and activation of hemopoietic cells. The GM-CSF locus may represent one of several target genes that are dysregulated in acute myeloid leukemia.
This article has been cited by other articles:
![]() |
M. Ullah, N. Pelletier, L. Xiao, S. P. Zhao, K. Wang, C. Degerny, S. Tahmasebi, C. Cayrou, Y. Doyon, S.-L. Goh, et al. Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes Mol. Cell. Biol., November 15, 2008; 28(22): 6828 - 6843. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nguyen, P. P. Pandolfi, Y. Aikawa, Y. Tagata, M. Ohki, and I. Kitabayashi Physical and functional link of the leukemia-associated factors AML1 and PML Blood, January 1, 2005; 105(1): 292 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. R. Biggs, and A. S. Kraft Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation J. Biol. Chem., December 17, 2004; 279(51): 53116 - 53125. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Johnson, A. G. Bert, G. R. Ryan, A. Condina, and P. N. Cockerill Granulocyte-Macrophage Colony-Stimulating Factor Enhancer Activation Requires Cooperation between NFAT and AP-1 Elements and Is Associated with Extensive Nucleosome Reorganization Mol. Cell. Biol., September 15, 2004; 24(18): 7914 - 7930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. P. Bristow and P. Shore Transcriptional regulation of the human MIP-1{alpha} promoter by RUNX1 and MOZ Nucleic Acids Res., June 1, 2003; 31(11): 2735 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hawwari, J. Burrows, M. A. Vadas, and P. N. Cockerill The Human IL-3 Locus Is Regulated Cooperatively by Two NFAT-Dependent Enhancers That Have Distinct Tissue-Specific Activities J. Immunol., August 15, 2002; 169(4): 1876 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Michaud, F. Wu, M. Osato, G. M. Cottles, M. Yanagida, N. Asou, K. Shigesada, Y. Ito, K. F. Benson, W. H. Raskind, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis Blood, February 15, 2002; 99(4): 1364 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bert, J. Burrows, A. Hawwari, M. A. Vadas, and P. N. Cockerill Reconstitution of T Cell-Specific Transcription Directed by Composite NFAT/Oct Elements J. Immunol., November 15, 2000; 165(10): 5646 - 5655. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Coles, P. Diamond, F. Occhiodoro, M. A. Vadas, and M. F. Shannon An Ordered Array of Cold Shock Domain Repressor Elements across Tumor Necrosis Factor-responsive Elements of the Granulocyte-Macrophage Colony-stimulating Factor Promoter J. Biol. Chem., May 5, 2000; 275(19): 14482 - 14493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Javed, B Guo, S Hiebert, J. Choi, J Green, S. Zhao, M. Osborne, S Stifani, J. Stein, J. Lian, et al. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription J. Cell Sci., January 6, 2000; 113(12): 2221 - 2231. [Abstract] [PDF] |
||||
![]() |
P. N. Cockerill, A. G. Bert, D. Roberts, and M. A. Vadas The human granulocyte-macrophage colony- stimulating factor gene is autonomously regulated in vivo by an inducible tissue-specific enhancer PNAS, December 21, 1999; 96(26): 15097 - 15102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |